Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tine G. Andreasen"'
Autor:
Emil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, Sara K. Elbæk, Sia V. Lindskrog, Ann Taber, Tine G. Andreasen, Trine Strandgaard, Michael Knudsen, Philippe Lamy, Mads Agerbæk, Jørgen B. Jensen, Lars Dyrskjøt
Publikováno v:
Christensen, E, Nordentoft, I, Birkenkamp-Demtroder, K, Elbæk, S K, Lindskrog, S V, Taber, A, Andreasen, T G, Strandgaard, T, Knudsen, M, Lamy, P, Agerbæk, M, Jensen, J B & Dyrskjøt, L 2023, ' Cell-free urine-and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer ', Clinical Cancer Research, vol. 29, no. 8, pp. 1582–1591 . https://doi.org/10.1158/1078-0432.CCR-22-3250
Purpose: To investigate the use of plasma and urine DNA mutation analysis for predicting neoadjuvant chemotherapy (NAC) response and oncological outcome in patients with muscle-invasive bladder cancer. Experimental Design: Whole-exome sequencing of t
Autor:
Lars Dyrskjøt, Jørgen B. Jensen, Mads Agerbæk, Philippe Lamy, Michael Knudsen, Trine Strandgaard, Tine G. Andreasen, Ann Taber, Sia V. Lindskrog, Sara K. Elbæk, Karin Birkenkamp-Demtröder, Iver Nordentoft, Emil Christensen
Clinical data and follow-up data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5455250d6214eb3d469c6019dfbe49c5
https://doi.org/10.1158/1078-0432.22633004
https://doi.org/10.1158/1078-0432.22633004
Autor:
Lars Dyrskjøt, Jørgen B. Jensen, Mads Agerbæk, Philippe Lamy, Michael Knudsen, Trine Strandgaard, Tine G. Andreasen, Ann Taber, Sia V. Lindskrog, Sara K. Elbæk, Karin Birkenkamp-Demtröder, Iver Nordentoft, Emil Christensen
Supplementary Fig. 1. Overview of sample availability and in-silico analysis of the limit of detection for the applied methodology.Supplementary Fig. 2. Comparison between mutations observed in primary and residual tumors at radical cystectomy (RC).S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0801f108c799ca6bb851bf70e519d51b
https://doi.org/10.1158/1078-0432.22633010.v1
https://doi.org/10.1158/1078-0432.22633010.v1
Autor:
Lars Dyrskjøt, Jørgen B. Jensen, Mads Agerbæk, Philippe Lamy, Michael Knudsen, Trine Strandgaard, Tine G. Andreasen, Ann Taber, Sia V. Lindskrog, Sara K. Elbæk, Karin Birkenkamp-Demtröder, Iver Nordentoft, Emil Christensen
Purpose:To investigate the use of plasma and urine DNA mutation analysis for predicting neoadjuvant chemotherapy (NAC) response and oncological outcome in patients with muscle-invasive bladder cancer.Experimental Design:Whole-exome sequencing of tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1599c159ac6f0ceacce3351ca061b11e
https://doi.org/10.1158/1078-0432.c.6533092
https://doi.org/10.1158/1078-0432.c.6533092
Autor:
Lars Dyrskjøt, Jørgen B. Jensen, Mads Agerbæk, Philippe Lamy, Michael Knudsen, Trine Strandgaard, Tine G. Andreasen, Ann Taber, Sia V. Lindskrog, Sara K. Elbæk, Karin Birkenkamp-Demtröder, Iver Nordentoft, Emil Christensen
Summarized metrics for WES data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42815d75a89f8a3de64ce1216d4bbd1
https://doi.org/10.1158/1078-0432.22490089.v1
https://doi.org/10.1158/1078-0432.22490089.v1
Autor:
Emil Christensen, Iver Nordentoft, Sara K. Elbæk, Karin Birkenkamp-Demtröder, Ann Taber, Tine G. Andreasen, Trine Strandgaard, Michael Knudsen, Philippe Lamy, Mads Agerbæk, Jørgen B. Jensen, Lars Dyrskjøt
PurposeInvestigate and compare the use of plasma- and urine DNA mutation analysis for predicting neoadjuvant chemotherapy (NAC) response and long-term oncological outcome in patients with muscle invasive bladder cancer.Experimental DesignWhole exome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ece45f945d15ac95738dc6347198212a
https://doi.org/10.1101/2022.10.24.22281440
https://doi.org/10.1101/2022.10.24.22281440
Autor:
Sia Viborg Lindskrog, George Laliotis, Karin Birkenkamp-Demtröder, Iver Nordentoft, Philippe Lamy, Elshaddai Z. White, Natalia Pajak, Tine G. Andreasen, Punashi Dutta, Meenakshi Malhotra, Shruti Sharma, Mark Calhoun, Adam ElNaggar, Minetta C. Liu, Mads Agerbæk, Jørgen B. Jensen, Lars Dyrskjøt
Publikováno v:
Cancer Research. 83:5600-5600
Background: Standard treatment of localized muscle invasive bladder cancer (MIBC) is neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC); however, only 40-50% respond to NAC and approx. 50% experience relapse. Evaluation of treatment e